Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Apr 22;21(4):e11864.
doi: 10.2196/11864.

Racial, Ethnic, and Socioeconomic Disparities in Web-Based Patient Portal Usage Among Kidney and Liver Transplant Recipients: Cross-Sectional Study

Affiliations

Racial, Ethnic, and Socioeconomic Disparities in Web-Based Patient Portal Usage Among Kidney and Liver Transplant Recipients: Cross-Sectional Study

Joel Wedd et al. J Med Internet Res. .

Abstract

Background: Kidney and liver transplant recipients must manage a complex care regimen after kidney transplant. Although the use of Web-based patient portals is known to improve patient-provider communication and health outcomes in chronic disease populations by helping patients manage posttransplant care, disparities in access to and use of portals have been reported. Little is known about portal usage and disparities among kidney and liver transplant recipients.

Objective: The aim of this study was to examine patient racial/ethnic, socioeconomic, and clinical characteristics associated with portal usage among kidney and liver transplant recipients.

Methods: The study included all adult kidney and liver transplant recipients (n=710) at a large academic transplant center in the Southeastern United States between March 2014 and November 2016. Electronic medical record data were linked with Cerner portal usage data. Patient portal use was defined as any portal activity (vs no activity) recorded in the Cerner Web-based portal, including viewing of health records, lab results, medication lists, and the use of secure messaging. Multivariable log-binomial regression was used to determine the patient demographic, clinical, and socioeconomic characteristics associated with portal usage, stratified by organ.

Results: Among 710 transplant recipients (n=455 kidney, n=255 liver), 55.4% (252/455) of kidney recipients and 48.2% (123/255) of liver recipients used the patient portal. Black patients were less likely to use the portal versus white patients among both kidney (57% black vs 74% white) and liver (28% black vs 55% white) transplant recipients. In adjusted multivariable analyses, kidney transplant recipients were more likely to use the portal if they had higher education; among liver recipients, patients who were white versus black and had higher education were more likely to use the portal.

Conclusions: Despite studies showing that patient portals have the potential to benefit transplant recipients as a tool for health management, racial and socioeconomic disparities should be considered before widespread implementation. Transplant centers should include portal training and support to all patients to encourage use, given its potential to improve outcomes.

Keywords: healthcare disparities; kidney transplantation; liver transplantation; patient engagement; patient portal.

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: None declared.

Figures

Figure 1
Figure 1
Overall portal activity among kidney (n=252) and liver (n=123) transplant recipients who registered for the patient portal between March 2014 and November 2016, 6 months before transplant to 2 years after transplant. Across the entire study period, portal functions were used at different rates among both.
Figure 2
Figure 2
Portal function activity viewed among kidney (n=252) and liver (n=123) recipients who registered for the patient portal between March 2014 and November 2016, 6 months before transplant to 2 years after transplant.

Similar articles

Cited by

References

    1. Rana A, Gruessner A, Agopian VG, Khalpey Z, Riaz IB, Kaplan B, Halazun KJ, Busuttil RW, Gruessner RW. Survival benefit of solid-organ transplant in the United States. JAMA Surg. 2015 Mar 1;150(3):252–9. doi: 10.1001/jamasurg.2014.2038.2100153 - DOI - PubMed
    1. Kim W, Lake J, Smith J, Skeans M, Schladt D, Edwards E, Harper A, Wainright J, Snyder J, Israni AK, Kasiske BL. OPTN/SRTR 2015 Annual Data Report: liver. Am J Transplant. 2017 Dec;17(Suppl 1):174–251. doi: 10.1111/ajt.14126. doi: 10.1111/ajt.14126. - DOI - DOI - PubMed
    1. Hart A, Smith J, Skeans M, Gustafson S, Wilk AR, Robinson A, Wainright J, Haynes CR, Snyder JJ, Kasiske BL, Israni AK. OPTN/SRTR 2016 Annual Data Report: kidney. Am J Transplant. 2018 Jan;18(Suppl 1):18–113. doi: 10.1111/ajt.14557. doi: 10.1111/ajt.14557. - DOI - DOI - PMC - PubMed
    1. Promraj R, Dumronggittigule W, Sirivatanauksorn Y, Ruenrom A, Tovikkai C, Limsrichamrern S, Kositamongkol P, Mahawithitwong P, Asavakarn S. Immunosuppressive medication adherence in liver transplant recipients. Transplant Proc. 2016 May;48(4):1198–201. doi: 10.1016/j.transproceed.2015.12.097.S0041-1345(16)00216-5 - DOI - PubMed
    1. Serper M, Patzer RE, Reese PP, Przytula K, Koval R, Ladner DP, Levitsky J, Abecassis MM, Wolf MS. Medication misuse, nonadherence, and clinical outcomes among liver transplant recipients. Liver Transpl. 2015 Jan;21(1):22–8. doi: 10.1002/lt.24023. doi: 10.1002/lt.24023. - DOI - DOI - PMC - PubMed

Publication types